期刊文献+

人抗甲状腺球蛋白抗体测定试剂盒行业标准的建立与验证 被引量:1

The Establishment and Verification of Industry Standards for Anti-Tg Ab Assay kits
下载PDF
导出
摘要 目的:对人抗甲状腺球蛋白抗体测定试剂盒行业标准可行性进行验证。方法:按照拟定行业标准的要求,选择不同免疫分析方法的试剂盒进行验证。结果:外观、空白限、线性、精密度、稳定性等指标符合要求,准确性项目有1批次试剂盒低浓度的测定结果不在±10.0%范围内,不符合拟定的行业标准要求。特异性项目中有1批次试剂盒不符合要求。结论:人抗甲状腺球蛋白抗体测定试剂盒行业标准制定合理,有助于规范此类试剂盒的技术要求和试验方法,从而提高此类试剂盒的产品质量,并为其监管提供依据。 Objective:To verify the feasibility of the industry Standards for Anti-Tg Ab assay kits.Methods:The kits of different immunoassay methods were selected for validation in accordance with industry Standards.Results:The appearance,limit of blank,linearity,accuracy and stability could meet requirements,while the accuracy of the test results of 1 batch of kits with low concentration is not within the range of±10.0%,which does not meet the proposed industry standards.In the specific project,1 batch of kits did not meet the requirements.Conclusion:The establishment of reasonable industry standards for Anti-Tg Ab assay kits is helpful to standardize the experimental methods and technical requirements of such kits so as to improve the product quality,and provide a basis for their supervision.
作者 孙楠 曲守方 于婷 黄杰 Sun Nan;Qu Shou-fang;Yu Ting;Huang Jie(National Institutes for Food and Drug Control,The Key Laboratory of Biotechnology Product Test Method and Its Standardization of The Ministry of Health,Beijing 100050,China)
出处 《中国药事》 CAS 2020年第4期454-458,共5页 Chinese Pharmaceutical Affairs
基金 国家高技术研究发展计划(863计划)新型体外诊断试剂质量评价体系和国家参考物质研究项目(编号2011AA02A115)。
关键词 人抗甲状腺球蛋白抗体 试剂盒 行业标准 Anti-Tg Ab kits industry Standards
  • 相关文献

参考文献4

二级参考文献52

  • 1柴红,陈泽泉,余永利.抗甲状腺球蛋白抗体增高水平及变化趋势对分化型甲状腺癌转移的预测价值[J].中华内分泌代谢杂志,2014,30(4). 被引量:14
  • 2DAI J, DENT W, ATKINSON J W, et al. Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid Cancer[J]. Clin Biochem, 1996, 29(5): 461- 465.
  • 3SPENCER C A, TAKEUCHI M, KAZAROSYAN M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic signifi- cance in patients with differentiated thyroid carcinoma[J]. J Clin Endocrinol Metab, 1998, 83(4) : 1121-1127.
  • 4LATROFA F, RICCI D, GRASSO L, et al. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies[J]. J Clin Endocri- nol Metab, 2008, 93(2): 591-596.
  • 5ROSARIO P W, MAIA F F, FAGUNDES T A, et al. Anti- thyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance[J]. Arq Bras Endocrinol Metahol, 2004, 48(4): 487-492.
  • 6OKOSIEME O E, EVANS C, MOSS I., et al. Thyroglobulin antibodies in serum of patients with differentiated thyroid Cancer: relationship between epitope specificities and thyro- globulin recovery[J]. Clin Chem, 2005, 51(4): 729-734.
  • 7SPENCER C A, BERGOGLIO L M, KAZAROSYAN M, et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differ- entiated thyroid carcinomas[J]. J Clin Endocrinol Metab, 2005, 90(10): 5566-5575.
  • 8SPENCER C A. Clinical review, Clinical utility of thyroglob- ulin antibody (TgAb) measurements for patients with differ- entiated thyroid cancers (DTC)[J]. J Clin Endocrinol Metab, 2011, 96(12) : 3615-3627,.
  • 9DUFOUR D R. Thyroglobulin antibodies--failing the test[J]. J Clin Endocrinol Metab, 2011, 96(5): 1276-1278.
  • 10MA C, KUANG A, XIE J, et al. Possible explanations for patients with discordant findings of serum tbyroglobulin and 131I whole-body scanning[J]. J Nucl Med, 2005, 46 (9) : 1473-1480.

共引文献235

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部